Factory Supply High Quality Cyproterone Acetate CAS 427-51-0

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: 427-51-0
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >99%
• Product Name: Cyproterone Acetate
• Classification: Pharmaceutical Grade
• Appearance: 99%
• CAS No.: 427-51-0
• Mf: C24h29clo4
• Test Method: HPLC
• Transport Package: Dry and Cool
• Specification: 1kg/Aluminum Foil Bag, 25kg/Cardboard Drum
• Trademark: Gina
• Origin: Shaanxi, China
• Production Capacity: 50000kilogram/ Month

Product Description

Cyproterone acetate (INN, USAN, BAN, JAN; abbreviated as CPA, sold under brand names such as Androcur and Cyprostat) is a synthetic steroidal antiandrogen, progestin, and antigonadotropin. Cyproterone acetate is primarily used in the treatment of androgen-related conditions by virtue of its ability to suppress androgenic activity in the body, an effect which it mediates by preventing endogenous androgens from interacting with the androgen receptor and by suppressing androgenbiosynthesis.
 

Product Name	Cyproterone Acetate
CAS No.	427-51-0
Purity	99%
Grade Standard	Medical Standard
MF	C24H29ClO4
MW	416.94
Test Method	HPLC
Other Name	Cyproterone Acetate Powder

 

Product Usage CPA has been in use as an antiandrogen since 1964, and was the first antiandrogen introduced for clinical use. CPA has been approved for the treatment of prostate cancer, precocious puberty, androgen-related dermatological conditions (such as acne, seborrhea, hirsutism, and androgenic alopecia), and to reduce sex drive in sex offenders. Combination formulations of CPA with ethinyl estradiol (a formulation sometimes referred to as co-cyprindiol) have been available as contraceptives since 1997. Other uses of CPA include the treatment of benign prostatic hyperplasia, priapism, hypersexuality, paraphilias, hot flashes, and hyperandrogenism in women.